BioClinica
Global clinical trial solutions. Real-world results.
- Solutions
- Science Library
- Support
- Partners
- About Us
*NEWTOWN, PA, February 4, 2010* – BioClinica, Inc., (NASDAQ: BIOC) a leading global provider of clinical trial services, has signed a three-year, multi-million dollar deal with Cephalon, Inc. for clinical trial technology and support services. As part of the Service Agreement, US-based data management staff at Cephalon will be hired by BioClinica to support clinical efforts of Cephalon.
*NEWTOWN, PA, February 3, 2010* -- BioClinica, Inc. (NASDAQ: BIOC) will release its financial results for the fourth quarter and full year ended December 31, 2009 on Wednesday, February 10, 2010.
*NEWTOWN, PA, February 2, 2010* – BioClinica™, Inc., (NASDAQ: BIOC), a global provider of clinical trial services, today announced the addition of Robert Sammis as the new vice president of finance for the company’s eClinical Division[eclinical-services/].
*NEWTOWN, PA, January 20, 2010* – BioClinica, Inc., (NASDAQ: BIOC) a leading global provider of clinical trial services, will be presenting at the Jefferies Inaugural Global Healthcare Services Conference on January 27, 2010 at 4:30 p.m. EST in New York City.
*NEWTOWN, PA, January 5, 2010* – BioClinica, Inc., (NASDAQ: BIOC) a leading global provider of clinical trial services,, will be presenting at the Sidoti & Company’s First 2010 Micro Cap Conference on January 11, 2010 at 9:50 a.m. EST at the Grand Hyatt Hotel in New York City.
As posted on eCliniqua's website:
As posted in The Wall Street Transcript: